Comparison of the Potency of the Lipid II Targeting Antimicrobials Nisin, Lacticin 3147 and Vancomycin Against Gram-Positive Bacteria

Probiotics and Antimicrobial Proteins

Volumn 4, Issue 2, 2012, Pages 108-115

  Iancu, Catalin ^a   Grainger, Aoife ^b   Field, Des ^b   Cotter, Paul D ^c,d   Hill, Colin ^b,d   Ross, R Paul ^c,d  

^a DUNAREA DE JOS UNIVERSITY OF GALATI   (Romania)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^d UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Antimicrobial; Bacteriocin; Lacticin 3147; Lantibiotic; Nisin; Vancomycin

Indexed keywords

LACTICIN 3147; LANTIBIOTIC; NISIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACILLUS CEREUS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

BACILLUS CEREUS; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; LISTERIA MONOCYTOGENES; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 84860424444     PISSN: 18671306     EISSN: 18671314     Source Type: Journal    
DOI: 10.1007/s12602-012-9095-x     Document Type: Article

References (69)

1. Allerberger F, Wagner M (2010) Listeriosis: a resurgent foodborne infection. Clin Microbiol Infec 16(1): 16-23.
2. Arnesen LA, Granum PE, Buisson C, Bohlin J, Nielsen-LeRoux C (2011) Using an insect model to assess correlation between temperature and virulence in Bacillus weihenstephanensis and Bacillus cereus. FEMS Microbiol Lett 317(2): 196-202.
3. Barna JC, Williams DH (1984) The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Annu Rev Microbiol 38: 339-357.
4. Begley M, Hill C, Ross RP (2006) Tolerance of Listeria monocytogenes to cell envelope-acting antimicrobial agents is dependent on SigB. Appl Environ Microb 72(3): 2231-2234.
5. Bierbaum G, Sahl HG (2009) Lantibiotics: mode of action, biosynthesis and bioengineering. Curr Pharm Biotechnol 10(1): 2-18.
6. Boakes S, Cortes J, Appleyard AN, Rudd BA, Dawson MJ (2009) Organization of the genes encoding the biosynthesis of actagardine and engineering of a variant generation system. Mol Microbiol 72(5): 1126-1136.
7. Bottone EJ (2010) Bacillus cereus, a volatile human pathogen. Clin Microbiol Rev 23(2): 382-391.
8. Breukink E, de Kruijff B (2006) Lipid II as a target for antibiotics. Nat Rev Drug Discov 5(4): 321-332.
9. Broadbent JR, Chou YC, Gillies K, Kondo JK (1989) Nisin inhibits several gram-positive, mastitis-causing pathogens. J Dairy Sci 72(12): 3342-3345.
10. Brotz H, Josten M, Wiedemann I, Schneider U, Gotz F, Bierbaum G, Sahl HG (1998) Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol 30(2): 317-327.
11. Castiglione F, Cavaletti L, Losi D, Lazzarini A, Carrano L, Feroggio M, Ciciliato I, Corti E, Candiani G, Marinelli F, Selva E (2007) A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp. Biochemistry-US 46(20): 5884-5895.
12. Castiglione F, Lazzarini A, Carrano L, Corti E, Ciciliato I, Gastaldo L, Candiani P, Losi D, Marinelli F, Selva E, Parenti F (2008) Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens. Chem Biol 15(1): 22-31.
13. Collins B, Curtis N, Cotter PD, Hill C, Ross RP (2010) The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics. Antimicrob Agents Ch 54(10): 4416-4423.
14. Collins B, Joyce S, Hill C, Cotter PD, Ross RP (2010) TelA contributes to the innate resistance of Listeria monocytogenes to nisin and other cell wall-acting antibiotics. Antimicrob Agents Ch 54(11): 4658-4663.
15. Cotter PD, Emerson N, Gahan CGM, Hill C (1999) Identification and disruption of lisRK, a genetic locus encoding a two-component signal transduction system involved in stress tolerance and virulence in Listeria monocytogenes. J Bacteriol 181(21): 6840-6843.
16. Cotter PD, Guinane CM, Hill C (2002) The LisRK signal transduction system determines the sensitivity of Listeria monocytogenes to nisin and cephalosporins. Antimicrob Ag Ch 46(9): 2784-2790.
17. Cotter PD, Hill C, Ross RP (2005) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3(10): 777-788.
18. Cotter PD, Hill C, Ross RP (2005) Bacterial lantibiotics: strategies to improve therapeutic potential. Curr Prot Pep Sc 6(1): 61-75.
19. Cotter PD, Deegan LH, Lawton EM, Draper LA, O'Connor PM, Hill C, Ross RP (2006) Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol Microbiol 62(3): 735-747.
20. Cotter PD, Draper LA, Lawton EM, McAuliffe O, Hill C, Ross RP (2006) Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147. Appl Environ Microb 72(6): 4492-4496.
21. Courvalin P (2006) Vancomycin resistance in gram-positive cocci. Clin Infect Dis 42(Suppl 1): S25-S34.
22. Crispie F, Twomey D, Flynn J, Hill C, Ross P, Meaney W (2005) The lantibiotic lacticin 3147 produced in a milk-based medium improves the efficacy of a bismuth-based teat seal in cattle deliberately infected with Staphylococcus aureus. J Dairy Res 72(2): 159-167.
23. De Buyser M-L, Dufour B, Maire M, Lafarge V (2001) Implication of milk and milk products in food-borne diseases in France and in different industrialised countries. Int J Food Microbiol 67(1-2): 1-17.
24. Deegan LH, Suda S, Lawton EM, Draper LA, Hugenholtz F, Peschel A, Hill C, Cotter PD, Ross RP (2006) Manipulation of charged residues within the two-peptide lantibiotic lacticin 3147. Microb Biotechnol 3(2): 222-234.
25. Ducey TF, Page B, Usgaard T, Borucki MK, Pupedis K, Ward TJ (2007) A single-nucleotide-polymorphism-based multilocus genotyping assay for subtyping lineage I isolates of Listeria monocytogenes. Appl Environ Microb 73(1): 133-147.
26. Ernst CM, Peschel A (2011) Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids. Mol Microbiol 80(2): 290-299.
27. Field D, Connor PM, Cotter PD, Hill C, Ross RP (2008) The generation of nisin variants with enhanced activity against specific gram-positive pathogens. Mol Microbiol 69(1): 218-230.
28. Field D, Quigley L, O'Connor PM, Rea MC, Daly K, Cotter PD, Hill C, Ross RP (2010) Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V. Microb Biotechnol 3(4): 473-486.
29. Galvez A, Lopez RL, Abriouel H, Valdivia E, Omar NB (2008) Application of bacteriocins in the control of foodborne pathogenic and spoilage bacteria. Crit Rev Biotechnol 28(2): 125-152.
30. Galvin M, Hill C, Ross RP (1999) Lacticin 3147 displays activity in buffer against gram-positive bacterial pathogens which appear insensitive in standard plate assays. Lett Appl Microbiol 28(5): 355-358.
31. Giraffa G (2002) Enterococci from foods. FEMS Microbiol Rev 26(2): 163-171.
32. Guinane CM, Cotter PD, Hill C, Ross RP (2006) Spontaneous resistance in Lactococcus lactis IL1403 to the lantibiotic lacticin 3147. FEMS Microbiol Lett 260(1): 77-83.
33. Hsu ST, Breukink E, Tischenko E, Lutters MA, de Kruijff B, Kaptein R, Bonvin AM, van Nuland NA (2004) The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nat Struct Mol Biol 11(10): 963-967.
34. King A, Phillips I (2001) The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates. J Antimicrob Ch 48(2): 219-223.
35. Klein G (2003) Taxonomy, ecology and antibiotic resistance of enterococci from food and the gastro-intestinal tract. Int J Food Microbiol 88(2-3): 123-131.
36. Klostermann K, Crispie F, Flynn J, Meaney WJ, Ross RP, Hill C (2010) Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate gram-positive pathogens associated with bovine mastitis. J Dairy Res 77(2): 231-238.
37. Kramer NE, Smid EJ, Kok J, de Kruijff B, Kuipers OP, Breukink E (2004) Resistance of gram-positive bacteria to nisin is not determined by Lipid II levels. FEMS Microbiol Lett 239(1): 157-161. doi: 10. 1016/j. femsle. 2004. 08. 033.
38. Lindback T, Hardy SP, Dietrich R, Sodring M, Didier A, Moravek M, Fagerlund A, Bock S, Nielsen C, Casteel M, Granum PE, Martlbauer E (2010) Cytotoxicity of the Bacillus cereus Nhe enterotoxin requires specific binding order of its three exoprotein components. Infect Immun 78(9): 3813-3821.
39. Mandin P, Fsihi H, Dussurget O, Vergassola M, Milohanic E, Toledo-Arana A, Lasa I, Johansson J, Cossart P (2005) VirR, a response regulator critical for Listeria monocytogenes virulence. Mol Microbiol 57(5): 1367-1380.
40. Martin-Belloso O, Raybaudi-Massilia RM, Mosqueda-Melgar J, Sobrino-Lopez A, Soliva-Fortuny R (2007) Shelf-life extension of fresh-cut "Fuji" apples at different ripeness stages using natural substances. Postharvest Biol and Tec 45(2): 265-275.
41. McAuliffe O, Ross RP, Hill C (2001) Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiol Rev 25(3): 285-308.
42. McGowan LL, Jackson CR, Barrett JB, Hiott LM, Fedorka-Cray PJ (2006) Prevalence and antimicrobial resistance of enterococci isolated from retail fruits, vegetables, and meats. J Food Prot 69(12): 2976-2982.
43. Mondino SSB, Castro ACD, Mondino PJJ, Carvalho MDS, Silva KMF, Teixeira LM (2003) Phenotypic and genotypic characterization of clinical and intestinal enterococci isolated from inpatients and outpatients in two Brazilian hospitals. Microb Drug Resist 9(2): 167-174.
44. Mootz HD, Kessler N, Linne U, Eppelmann K, Schwarzer D, Marahiel MA (2002) Decreasing the ring size of a cyclic nonribosomal peptide antibiotic by in-frame module deletion in the biosynthetic genes. J Am Chem Soc 124(37): 10980-10981.
45. Morgan SM, Galvin M, Ross RP, Hill C (2001) Evaluation of a spray-dried lacticin 3147 powder for the control of Listeria monocytogenes and Bacillus cereus in a range of food systems. Lett Appl Microbiol 33(5): 387-391.
46. Morgan SM, O'Connor PM, Cotter PD, Ross RP, Hill C (2005) Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrob Agents Ch 49(7): 2606-2611.
47. Mota-Meira M, Lacroix C, LaPointe G, Lavoie MC (1997) Purification and structure of mutacin B-Ny266: a new lantibiotic produced by Streptococcus mutans. FEBS Lett 410(2-3): 275-279.
48. Mota-Meira M, LaPointe G, Lacroix C, Lavoie MC (2000) MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens. Antimicrob Agents Ch 44(1): 24-29.
49. Mota-Meira M, Morency H, Lavoie MC (2005) In vivo activity of mutacin B-Ny266. J Antimicrob Ch 56(5): 869-871.
50. Niu WW, Neu HC (1991) Activity of Mersacidin, a novel peptide, compared with that of vancomycin, Teicoplanin, and Daptomycin. Antimicrob Agents Ch 35(5): 998-1000.
51. O'Mahony J, Carroll J, Draper LA, O'Connor PM, Coffey A, Hill C, Ross RP, Cotter PD (2010) Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria. Int J Antimicrob Ag 36(2): 132-136.
52. Piper C, Cotter PD, Draper LA, Ross RP, Hill C (2009) A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J Antimicrob Chemoth 63(3): 546-551.
53. Piper C, Cotter PD, Ross RP, Hill C (2009) Discovery of medically significant lantibiotics. Curr Drug Discov Technol 6(1): 1-18.
54. Rivera AM, Boucher HW (2011) Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci. Mayo Clin Proc 86(12): 1230-1242. doi: 10. 4065/mcp2011. 0514.
55. Ross RP, Morgan S, Hill C (2002) Preservation and fermentation: past, present and future. Int J Food Microbiol 79(1): 3-16.
56. Ross RP, Rea MC, Clayton E, O'Connor PM, Shanahan F, Kiely B, Hill C (2007) Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains. J Med Microbiol 56(7): 940-946.
57. Ruzin A, Severin A, Moghazeh SL, Etienne J, Bradford PA, Projan SJ, Shlaes DM (2003) Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus. BBA-Gen Subjects 1621(2): 117-121.
58. Scannell AG, Ross RP, Hill C, Arendt EK (2000) An effective lacticin biopreservative in fresh pork sausage. J Food Prot 63(3): 370-375.
59. Schlech WF III (2000) Foodborne listeriosis. Clin Infect Dis 31(3): 770-775.
60. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR, Staphylococ GI (1999) Emergence of vancomycin resistance in Staphylococcus aureus. New Engl J Med 340(7): 493-501.
61. Stack HM, Sleator RD, Bowers M, Hill C, Gahan CG (2005) Role for HtrA in stress induction and virulence potential in Listeria monocytogenes. Appl Environ Microb 71(8): 4241-4247.
62. Suda S, Cotter PD, Hill C, Ross RP (2011) Lacticin 3147: biosynthesis, molecular analysis, immunity, bioengineering and applications. Curr Prot Pep Sc (in print).
63. Sussmuth RD, Wohlleben W (2004) The biosynthesis of glycopeptide antibiotics-a model for complex, non-ribosomally synthesized, peptidic secondary metabolites. Appl Microbiol Biotechnol 63(4): 344-350.
64. Thedieck K, Hain T, Mohamed W, Tindall BJ, Nimtz M, Chakraborty T, Wehland J, Jansch L (2006) The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes. Mol Microbiol 62(5): 1325-1339.
65. Upton M, Al-Mahrous MM (2011) Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application. Expert Opin Drug Disc 6(2): 155-170.
66. Viguier C, Arora S, Gilmartin N, Welbeck K, O'Kennedy R (2009) Mastitis detection: current trends and future perspectives. Trends Biotechnol 27(8): 486-493.
67. Walsh FM, Amyes SG (2004) Microbiology and drug resistance mechanisms of fully resistant pathogens. Curr Opin Microbiol 7(5): 439-444. doi: 10. 1016/j. mib. 2004. 08. 007.
68. Watanabe S, Kobayashi N, Quinones D, Hayakawa S, Nagashima S, Uehara N, Watanabe N (2009) Genetic diversity of the low-level vancomycin resistance gene vanC-2/vanC-3 and identification of a novel vanC subtype (vanC-4) in Enterococcus casseliflavus. Microb Drug Resist 15(1): 1-9.
69. Wiedemann I, Bottiger T, Bonelli RR, Wiese A, Hagge SO, Gutsmann T, Seydel U, Deegan L, Hill C, Ross P, Sahl HG (2006) The mode of action of the lantibiotic lacticin 3147-a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol Microbiol 61(2): 285-296.